Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population

Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method – Analysis of 2010 Taiwanese patients

(2009) Chien-Hung Chen et al.   EUROPEAN JOURNAL OF CANCER

Prognostic scores for hepatocellular carcinoma: none is the winner

(2009) Calogero Cammà et al.   LIVER INTERNATIONAL

Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials

(2008) S. Collette et al.   ANNALS OF ONCOLOGY

Evaluation of the prognostic powers of various tumor status grading scales in patients with hepatocellular carcinoma

(2008) Yeon Seok Seo et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Transarterial Ethanol Ablation of Hepatocellular Carcinoma with Lipiodol–Ethanol Mixture: Phase II Study

(2008) Simon C.H. Yu et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Seven Staging Systems in Cirrhotic Patients With Hepatocellular Carcinoma in a Cohort of Patients Who Underwent Radiofrequency Ablation With Complete Response

(2007) Alfredo Guglielmi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY